This triple-pathway may increase fat burning and reduce appetite more than current GLP-1 medicines
This is why ophthalmology follow-up is emphasized when glucose is changing significantly
Women with severe vasomotor symptoms should be treated with hormone therapy at the lowest dose possible per guidelines, and tirzepatide should remain top-of-the-list for weight loss in persons with obesity or overweight with comorbid illness, Uzmann says
Who Is Most at Risk for GLP-1-Related Joint Discomfort Individuals with a family history of arthritis, prior joint injuries, or inflammatory conditions may be more vulnerable to joint pain during GLP-1 therapy
10.1007/s00125-017-4336-x 104 SayedaliE.YalinA
Whether Zepbound or Wegovy, we provide personalized guidance and support to ensure safe, effective, and sustainable weight management